FDA applicant
Medrad, Inc.
FDA records 105 decisions for Medrad, Inc. (Indianola, PA) from 1976 to 2014: 105 510(k) clearances. Most are in product codes DXT (Injector And Syringe, Angiographic) and MOS (Coil, Magnetic Resonance, Specialty). Its devices cite 78 predicates, 43 of them its own earlier devices. 26 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Medrad, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2014
2026 so far, outlined.
Recalls per year
1in 2026
Class I Class II/III not classified
Planning a device like Medrad, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Medrad”
FDA records each applicant name separately; these may or may not be the same firm.